English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The objective of this study was to analyze the safety and tolerance of a cutaneous protective sock made with Re-genactiv® technology in patients with dermatoporosis and / or skin changes due to chronic venous insufficiency.A prospective study was carried out in the wound consultation of the Vicente Soldevilla Peripheral Specialties Center between November and December 2018. All patients who attended the consultation of wounds that presented dermatoporosis on the skin of the leg and / or dermal alterations were included for chronic venous insufficiency.89% (n = 18) of the patients did not present adverse events, a single patient (5%) presented an adverse event in the form of erosion. Another patient (5%) could not use the sock because it did not fit the perimeter of his leg.48% (n = 10) of the patients rated the comfort of the sock with 9 or 10, 38% (n = 8) between 7 and 8, and only 5% with 6 out of 10 on the Likert scale . The patient who could not use the sock continuously did not value this item. 90% (n = 18) of the patients showed no pain during the time of use of the sock. 10% (n = 2) of the patients reached a pain level of 3-4 on the EVA scale.The use of a protective sock made with Regenactiv® textile technology by patients with dermatoporosis and / or skin involvement secondary to chronic venous insufficiency produces few adverse effects and is well tolerated. In addition, it can be used under therapeutic compression devices.

Seguridad y grado de aceptación de un calcetín protector cutáneo en pacientes con dermatoporosis y/o cambios cutáneos por insuficiencia venosa crónica